Mark Clement
Geschäftsführer bei Revitope Oncology, Inc.
Profil
Mark Rowland Clement has held positions as Chief Operating Officer & Director at Revitope Oncology, Inc. and Director at Revitope Ltd.
Aktive Positionen von Mark Clement
Unternehmen | Position | Beginn |
---|---|---|
Revitope Ltd.
Revitope Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Revitope Ltd. is a British biotechnology company that operates as a developer of cancer therapies. The company is based in Hertfordshire, UK and is part of Revitope Oncology, Inc. | Direktor/Vorstandsmitglied | 13.01.2015 |
Revitope Oncology, Inc.
Revitope Oncology, Inc. Hospital/Nursing ManagementHealth Services Revitope Oncology, Inc. develops a programmable antibody circuit pipeline in particular redirecting T cells to tumors. The company was founded by Andrew Allen and Mark Cobbold and is headquartered in Cambridge, MA. | Geschäftsführer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Revitope Ltd.
Revitope Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Revitope Ltd. is a British biotechnology company that operates as a developer of cancer therapies. The company is based in Hertfordshire, UK and is part of Revitope Oncology, Inc. | Commercial Services |
Revitope Oncology, Inc.
Revitope Oncology, Inc. Hospital/Nursing ManagementHealth Services Revitope Oncology, Inc. develops a programmable antibody circuit pipeline in particular redirecting T cells to tumors. The company was founded by Andrew Allen and Mark Cobbold and is headquartered in Cambridge, MA. | Health Services |